DOW JONES27,960.80-1031.61 -3.56%
S&P 5003,225.89-111.86 -3.35%
NASDAQ9,221.28-355.31 -3.71%

Biogen Q4 Adj. EPS $8.34 Beats $7.92 Estimate, Sales $3.67B Beat $3.52B Estimate; Sees FY20 Adj. EPS $31.50-$33.50, Sales $14B-$14.3B

Biogen (NASDAQ:BIIB) reported quarterly earnings of $8.34 per share which beat the analyst consensus estimate of $7.92 by 5.3 percent. This is a 19.31 percent increase over earnings of $6.99 per share from the same

Benzinga · 01/30/2020 11:55

Biogen (NASDAQ:BIIB) reported quarterly earnings of $8.34 per share which beat the analyst consensus estimate of $7.92 by 5.3 percent. This is a 19.31 percent increase over earnings of $6.99 per share from the same period last year. The company reported quarterly sales of $3.67 billion which beat the analyst consensus estimate of $3.52 billion by 4.26 percent. This is a 4.08 percent increase over sales of $3.526 billion the same period last year.  -Reuters